Improving Patient Selection is Key to Immunotherapy Success in Breast Cancer, Expert Says – Targeted Oncology
Targeted Oncology |
Improving Patient Selection is Key to Immunotherapy Success in Breast Cancer, Expert Says
Targeted Oncology In certain patients with triple-negative breast cancer, the combination of immunotherapy and chemotherapy is showing promising response rates, said ESO Umberto Veronesi Memorial Award Winner Giuseppe Curigliano, MD, PhD, who addressed genetic … |
